Public map story

Eve Hewson

News pulse 2026-08-26 · Reuters: The U.S. Food and Drug Administration approves the daraxonrasib drug as a treatment for metastatic pancreatic cancer, making it the first RAS inhibitor drug to be approved for the disease. This came after a previous study showed that it nearly doubled the survival rate for patients compared to chemotherapy.

party · Thessaloniki, GR · 2 likes · 2 replies